We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

83 hedge funds and large institutions have $70.2M invested in ENZON PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 83 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less call options, than puts

Call options by funds: $2K | Put options by funds: $20K

Holders
83
Holders Change
+83
Holders Change %
–
% of All Funds
2.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
83
Increased
–
Reduced
–
Closed
–
Calls
$2K
Puts
$20K
Net Calls
-$18K
Net Calls Change
-$18K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$15.4M +$22.5M +7,691,453 New
IC
2
Icahn Carl
Florida
$11.8M +$17.3M +5,904,863 New
BIT
3
BlackRock Institutional Trust
California
$5.39M +$7.89M +2,694,548 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.57M +$5.22M +1,782,757 New
BFA
5
BlackRock Fund Advisors
California
$2.77M +$4.06M +1,385,949 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$2.55M +$3.74M +1,276,647 New
State Street
7
State Street
Massachusetts
$2.47M +$3.61M +1,234,169 New
BIP
8
Brandes Investment Partners
California
$2.05M +$3.01M +1,026,723 New
Renaissance Technologies
9
Renaissance Technologies
New York
$1.82M +$2.67M +910,308 New
BA
10
BlackRock Advisors
Delaware
$1.62M +$2.37M +809,674 New
MFP
11
Michael F. Price
$1.5M +$2.19M +748,200 New
U
12
UBS
Switzerland
$1.41M +$2.07M +706,831 New
Fidelity Investments
13
Fidelity Investments
Massachusetts
$1.32M +$1.94M +661,329 New
Northern Trust
14
Northern Trust
Illinois
$1.13M +$1.66M +566,442 New
GCM
15
Gruss Capital Management
New York
$1.03M +$1.51M +517,000 New
Charles Schwab
16
Charles Schwab
California
$779K +$1.2M +409,800 New
FPA
17
First Pacific Advisors
California
$760K +$1.11M +379,826 New
Invesco
18
Invesco
Georgia
$756K +$1.11M +377,861 New
SO
19
STRS Ohio
Ohio
$707K +$1.03M +353,500 New
HMC
20
Harbert Management Corporation
Alabama
$703K +$1.03M +351,700 New
Morgan Stanley
21
Morgan Stanley
New York
$663K +$969K +331,147 New
Goldman Sachs
22
Goldman Sachs
New York
$620K +$908K +310,236 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$520K +$762K +260,169 New
ARC
24
Absolute Return Capital
Massachusetts
$489K +$716K +244,478 New
TC
25
TFS Capital
Pennsylvania
$475K +$696K +237,697 New
1
2 3 4

ENZN Hedge Fund Activity: Q2 2013 in Review

83 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2013, worth a combined $70.2M.

Buyers outnumbered sellers: 83 funds opened new ENZN positions and 0 closed out — a net gain of 83 holders — while 0 added to existing stakes and 0 trimmed.

  • 83 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $70.2M of ENZON PHARMACEUTICALS INC stock for Q2 2013.
  • 83 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +83 holders.

Based on aggregated 13F filings for Q2 2013.